Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital‐acquired infections: a scientific review

M Nguyen, SG Joshi - Journal of applied microbiology, 2021 - academic.oup.com
Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …

Bloodstream infections in critically ill patients: an expert statement

JF Timsit, E Ruppé, F Barbier, A Tabah… - Intensive care medicine, 2020 - Springer
Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …

Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind …

RG Wunderink, Y Matsunaga, M Ariyasu… - The Lancet Infectious …, 2021 - thelancet.com
Background Nosocomial pneumonia due to multidrug-resistant Gram-negative pathogens
poses an increasing challenge. We compared the efficacy and safety of cefiderocol versus …

Timing of antibiotic therapy in the ICU

MH Kollef, AF Shorr, M Bassetti, JF Timsit, ST Micek… - Critical Care, 2021 - Springer
Severe or life threatening infections are common among patients in the intensive care unit
(ICU). Most infections in the ICU are bacterial or fungal in origin and require antimicrobial …

Expert consensus-based clinical practice guidelines management of intravascular catheters in the intensive care unit

JF Timsit, J Baleine, L Bernard, S Calvino-Gunther… - Annals of intensive …, 2020 - Springer
Abstract The French Society of Intensive Care Medicine (SRLF), jointly with the French-
Speaking Group of Paediatric Emergency Rooms and Intensive Care Units (GFRUP) and …

Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia

N Peiffer-Smadja, L Bouadma, V Mathy, K Allouche… - Critical care, 2020 - Springer
Background Early appropriate antibiotic therapy reduces morbidity and mortality of severe
pneumonia. However, the emergence of bacterial resistance requires the earliest use of …

Source control in the management of sepsis and septic shock

JJ De Waele, M Girardis, I Martin-Loeches - Intensive care medicine, 2022 - Springer
Source control is an important element of the treatment of sepsis and septic shock [1]. Lack
or delay of source control has been associated with worse outcomes for patients with …

Antimicrobial de-escalation as part of antimicrobial stewardship in intensive care: no simple answers to simple questions—a viewpoint of experts

JJ De Waele, J Schouten, B Beovic, A Tabah… - Intensive care …, 2020 - Springer
Antimicrobial de-escalation (ADE) is defined as the discontinuation of one or more
components of combination empirical therapy, and/or the change from a broad-spectrum to …

The role of the microbiota in the management of intensive care patients

P Szychowiak, K Villageois-Tran, J Patrier… - Annals of intensive …, 2022 - Springer
The composition of the gut microbiota is highly dynamic and changes according to various
conditions. The gut microbiota mainly includes difficult-to-cultivate anaerobic bacteria, hence …

Antibacterial mechanism and transcriptomic analysis of a near-infrared triggered upconversion nanoparticles@AgBiS2 for synergetic bacteria-infected therapy

S Chen, Z Chu, L Cao, L Xu, Q Jin, N Liu, B Chen… - Nano Research, 2022 - Springer
Methicillin-resistant Staphylococcus aureus (MRSA) has become a rising clinical problem as
its occurrence has increased due to the overuse and misuse of antibiotics. In this work …